FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/04/2023
Voltar para busca
Dado oficial do USPTO
MOLECULE.ONE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
19/04/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 42
Data de depósito
02/09/2019
Data de registro
15/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/11/2022
Última transação
15/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
PL
Examinador
XU, ELAINE YILIN
Unidade examinadora
N90
Localização atual
TMO LAW OFFICE 127
Descrição da marca
The mark consists of a concentric design comprised of two circles, one within the other, made up of dots. The dots in the outer circle are larger than those in the inner circle, with one stand alone dot to the upper right of the concentric design followed by the words "Molecule.one".
Titulares e representantes
Titulares
M. O. (pessoa física)
Representantes
Peter J. Rosene McBrayer PLLC
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for use in data analysis in the field of medicine; Downloadable Computer software for use in systems to support medical decision-making; Humanoid robots with artificial intelligence; Downloadable Software based on artificial intelligence technology for use in designing synthesis paths; Downloadable Computer software for use in data analysis capable of understanding and analyzing human questions and formulating answers to these questions; Downloadable computer program to support decision making process in the field of medicine and pharmacywhich is based on artificial intelligence
Classe 42
Designinstallationupdating and rental of computer software for use in the field of medicine and pharmacy; Designinstallationupdating and implementation of computer software capable of understanding and analyzing human questions and formulating answers to these questions; Development of computer vision algorithms being a type of software development service; Design and development of computer software in the fields of artificial intelligencedeep learningdistributed computingvirtualization and machine learning; Researchdesign and development services of computer software relating to pharmaceutical products data processing by computer vision; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for use in machine learning at the initialbeing earlydrug discovery stage; Creating software enabling the design of synthesis paths for organic compounds taking into account the creator's preferences; Providing online non-downloadable software for the design of synthesis pathways
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/03/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
07/03/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
15/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/08/2022
PUBO
PUBLISHED FOR OPPOSITION
30/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
28/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
28/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2022
GNFR
FINAL REFUSAL E-MAILED
01/02/2022
CNFR
FINAL REFUSAL WRITTEN
01/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/10/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/09/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/06/2021
GNRT
NON-FINAL ACTION E-MAILED
21/06/2021
CNRT
NON-FINAL ACTION WRITTEN
21/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/11/2020
GNSL
LETTER OF SUSPENSION E-MAILED
24/11/2020
CNSL
SUSPENSION LETTER WRITTEN
24/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2020
RFNT
REFUSAL PROCESSED BY IB
29/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/05/2020
RFRR
REFUSAL PROCESSED BY MPU
08/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/04/2020
CNRT
NON-FINAL ACTION WRITTEN
24/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
21/04/2020
DOCK
ASSIGNED TO EXAMINER
17/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/04/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOLECULE.ONE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.